-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Coeptis Therapeutics Holdings, Inc. quarterly/annual Revenues history and growth rate from Q1 2022 to Q2 2024.
- Coeptis Therapeutics Holdings, Inc. Revenues for the quarter ending June 30, 2024 was $0.000.
- Coeptis Therapeutics Holdings, Inc. Revenues for the twelve months ending June 30, 2024 was $0.000.
- Coeptis Therapeutics Holdings, Inc. annual Revenues for 2023 was $0.000.
- Coeptis Therapeutics Holdings, Inc. annual Revenues for 2022 was $0.000, a 100% decline from 2021.